Working in Pharma 100 years ago; Woman at work in lab coats Working in Pharma 100 years ago; Woman at work in lab coats

100 Years of Expertise in Vaccines

It is with great honor that IDT Biologika celebrates its 100th anniversary in 2021. Companies that reach this milestone typically share certain characteristics, like commitment and stability, but also inevitably requirements like adaptability and innovation. To thrive over 100 years, through much change, takes all these character traits and more, applied under consistent stewardship over the decades.

Enjoy our remarkable one hundred years history in this footage
01
05
02
05
03
05
04
05
05
05
100 years in five articles

Learn more about IDT Biologika’s exciting history in five articles published over five months in 2021 to celebrate our centenary:

Image 1921 - 1945
1921 – 1945
Image 1945-1990
1945 – 1990
Image IDT Biologikas Key People
Key People
Image 1990-2021
1990 – 2021
Laboratory technicians look at liquid in a glass (our history)
Our Vision

Our anniversary brochure

Read more about our company – about our history, our plans for the future and the people in the company.

You are currently viewing a placeholder content from ISSUU. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Never have we seen a clearer embodiment of this than in our centenary year – when you think of the global COVID-19 pandemic on one hand and the rapid growth of cell and gene therapies and other exciting modalities on the other.

IDT continues to invest in state-of-the-art technologies, to nurture generations of expertise in our workforce, and to focus on innovation to ensure we remain at the forefront of development and manufacturing in products based on live viruses. Our goal is to continue to adapt and dedicate ourselves to whatever is needed in the coming years. And, who knows, that focus on the present may lead us to our next 100-year anniversary!

Timeline 1921-2024

1921

The company’s roots date back to the foundation of the Bacterial Institute of the Anhalt counties (Bakteriologisches Institut der Anhaltischen Kreise) in Dessau, Germany.

First institute building at Neumarkt 5 in Dessau
1925

Vaccine production began in 1925 with the manufacture of a human tuberculosis vaccine and a swine erysipelas vaccine.

work in the pharmaceutical sector 100 years ago
1930

Rising demand for industrial production of sera for passive immunization of humans and animals led to the foundation of the Anhalt Serum Institute Dessau GmbH (Anhaltisches Serum Institut Dessau GmbH (ASID).

The Hygienic Institute Anhalt in Dessau with its extensions (ASID) in 1938.
1945

Production of vaccines and diagnostic agents to combat infectious diseases resulted in the newly formed Research Institute for Vaccines (Forschungsinstitut für Impfstoffe).

work in the pharmaceutical sector 100 years ago
1960

Government programs to prevent and treat animal infectious diseases shaped the company’s strategic direction towards research and production.

Pig farm near Dessau
1980

Production capacities for human medicines were spun off. The company was renamed Vaccine Plant Dessau-Tornau (Impfstoffwerk Dessau-Tornau).

Working in the pharmaceutical sector 100 years ago in facility management
1993

Entrepreneur Hartmut Klocke privatized the corporation.

Employee works on safety workbench
1999

The company expanded production capacities and started to focus on two company businesses: Contract development and manufacturing of human vaccines and biologics, development, production, and distribution of animal health products.

Employees with a shelf full of roller bottles
2007

Due to international growth of the business, the company was renamed IDT Biologika.

IDT Biologika altes und neues Logo
2015

IDT Biologika’s presence expanded to North America with the acquisition of the contract manufacturing division of Aeras TB in Rockville, Maryland.

Rockville, Maryland
2019

IDT Biologika sold its animal health business to Ceva Santè Animale, enabling the company to focus solely on custom development and manufacturing of human vaccines and biologics as a CDMO.

plant with filled syringes
2021

IDT Biologika celebrates its 100th anniversary and specializes in contract development and manufacturing of vaccines, viral vectors for gene therapy products, and dosage form supply of liquid and lyophilized biologics.

IDT Biologika Company Building
2023

First German company which has its pandemic readiness confirmed by the German government.

Employees on filling Line